$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of Mavacamten’s original drug manufacturers
2026-02-01 22:25:32
Check Details
Detailed explanation of precautions when using tenofovir alafenamide tablets (Vemlidy)
2026-02-01 22:25:32
Check Details
Safety assessment and recommendations for long-term use of Lemborexant
2026-02-01 22:25:32
Check Details
Which company produces Lusutrombopag and analysis of drug sales channels
2026-02-01 22:25:32
Check Details
Omarigliptin usage, dosage and medication precautions explained
2026-02-01 22:25:32
Check Details
Detailed analysis of whether lecanemab-LEQEMBI is included in medical insurance and patient self-payment
2026-02-01 22:25:32
Check Details
Analysis of golodirsen side effects, adverse reactions and medication safety recommendations
2026-02-01 22:25:32
Check Details
An analysis of the clinical medication regimens and precautions for different patients with Vidicitomab (Aidexi)
2026-02-01 22:25:32
Check Details
Isatuximab is produced and developed by which company?
2026-02-01 22:25:32
Check Details
Whether capivasertib tablets (capivasertib) has been included in the medical insurance and reimbursement policy
2026-02-01 22:25:32
Check Details
The latest market price and reference cost of Guselkumab in 2026
2026-02-01 22:25:32
Check Details
Tenapanor reimbursement ratio and patient cost analysis
2026-02-01 22:25:32
Check Details
1
2
...
2380
2381
2382
2383
2384
2385
2386
...
10229
10230
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Zanidatamab (Ziihera): HER2 Bispecific Antibody Plus Immunotherapy for First-Line Gastric Cancer
2
Acalabrutinib Dosing and Efficacy Guide: Administration, Response Evaluation, and Safety
3
Osimertinib Treatment and Dosing Guide: Efficacy, Administration, and Precautions
4
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights
5
Ceritinib Dosing Guide: 450mg Once Daily with Food – Key Administration Points
6
Ruxolitinib Drug Safety Guide: Drug Interactions, Hepatic/Renal Function, and Infection Risk Management
7
Revumenib Mechanism Explained: Targeting menin-KMT2A Interaction to Reshape Leukemia Cell Fate
8
Pretomanid Combination Therapy Safety Guide: BPaL Regimen Adverse Reaction Recognition and Monitoring
9
Asciminib (Scemblix): Targeted Mechanism, Dosing Regimens, and Missed-Dose Guidance
10
Vigabatrin (Sabril): Mechanism of Action, Pharmacokinetics, and Safety Monitoring
11
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol
12
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes